Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Intellia Thera CS (NQ: NTLA ) 23.58 -0.05 (-0.21%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Intellia Thera CS < Previous 1 2 ... 8 9 10 11 12 13 14 15 Next > What's the Best Way to Invest in Genetics Stocks? June 07, 2021 Here are some of our experts' favorite gene editing plays for the long run. Via The Motley Fool This Genetics Stock Could Have a Bright Future June 03, 2021 Here's one genetics play that you might want to put on your radar. Via The Motley Fool Biotech Stocks Cruise Through The Volatility May 25, 2021 The XLV Healthcare Select SPDR is up 10% YTD. Via Talk Markets 10 Health Care Stocks Showing Unusual Options Activity In Today's Session May 14, 2021 This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... Via Benzinga Intellia Therapeutics, Inc. (NTLA) Q1 2021 Earnings Call Transcript May 07, 2021 NTLA earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge May 01, 2021 Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... Via Benzinga Exposures Product Safety Benzinga's Top Ratings Upgrades, Downgrades For May 7, 2021 May 07, 2021 Upgrades Loop Capital upgraded the previous rating for Roku Inc (NASDAQ:ROKU) from Hold to Buy. In the first quarter, Roku showed an EPS of $0.54, compared to $0.45 from... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2021 May 04, 2021 Upgrades For Genuine Parts Co (NYSE:GPC), Goldman Sachs upgraded the previous rating of Sell to Neutral. In the first quarter, Genuine Parts showed an EPS of $1.50,... Via Benzinga The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom May 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety 3 Exciting Biotech Stocks to Buy Right Now April 30, 2021 Gene therapies could be poised to enter an era of extraordinarily rapid advancement. Via The Motley Fool CRISPR Stocks: The Big Analyst Call Destroying CRSP, NTLA, EDIT Stocks Today April 16, 2021 A "sell" rating is one thing, but a 50% price target? It's no wonder Editas stock is crashing, and taking other gene-editing stocks with it. Via InvestorPlace The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data April 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 7) Aclaris Therapeutics, Inc... Via Benzinga Exposures Product Safety < Previous 1 2 ... 8 9 10 11 12 13 14 15 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.